Sustained reduction in health care costs after adjunctive treatment of graded intensive short-term dynamic psychotherapy in patients with psychotic disordersVisa övriga samt affilieringar
2015 (Engelska)Ingår i: Psychiatry Research, ISSN 0165-1781, E-ISSN 1872-7123, Vol. 228, nr 3, s. 538-543Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
The aim of this pilot study was to evaluate the changes in symptom severity and long-term health care cost after intensive short-term dynamic psychotherapy (ISTDP) individually tailored and administered to patients with psychotic disorders undergoing standard psychiatric care. Eleven therapists with different levels of expertise delivered an average of 13 one-hour sessions of graded ISTDP to 38 patients with psychotic disorders. Costs for health care services were compiled for a one-year period prior to the start of ISTDP (baseline) along with four one-year periods after termination. Two validated self-report scales, the Brief Symptom Inventory and the Inventory of Interpersonal Problems, were administered at intake and termination of ISTDP. Results revealed that health care cost reductions were significant for the one-year post-treatment period relative to baseline year, for both physician costs and hospital costs, and the reductions were sustained for the follow-up period of four post-treatment years. Furthermore, at treatment termination self-reported symptoms and interpersonal problems were significantly reduced. These preliminary findings suggest that this brief adjunctive psychotherapy may be beneficial and reduce costs in selected patients with psychotic disorders, and that gains are sustained in long-term follow-up. Future research directions are discussed. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
Ort, förlag, år, upplaga, sidor
ELSEVIER IRELAND LTD , 2015. Vol. 228, nr 3, s. 538-543
Nyckelord [en]
Psychosis; Intensive short-term dynamic; psychotherapy; Clinical outcomes; Economic evaluation; Long-term effects
Nationell ämneskategori
Medicinska och farmaceutiska grundvetenskaper
Identifikatorer
URN: urn:nbn:se:liu:diva-121435DOI: 10.1016/j.psychres.2015.05.056ISI: 000360251400045PubMedID: 26106054OAI: oai:DiVA.org:liu-121435DiVA, id: diva2:855119
Anmärkning
Funding Agencies|Dalhousie University Department of Psychiatry; Nova Scotia Department of Health and Wellness; Mental Health Foundation of Nova Scotia; Capital Health Mental Health Program
2015-09-182015-09-182018-01-11